The headline reads: Favorable News from Advanced Cell Technology and Stem Cell Inc. Boosts Optimism in Regenerative Medicine Industry. Well maybe, but the markets not buying it. Geron closed up 2 cents at $2.02, on 1.6 million shares, the price range for today was $1.98-$2.14. Thinking of buying a few calls under $2, ACTC closed down just a little under 11 cent. Trying to buy more around .105.
Good luck in this rigged casino,
No comments:
Post a Comment